CorVel (NASDAQ:CRVL) Stock Price Down 5.7% – What’s Next?

CorVel Corp. (NASDAQ:CRVL) was down 5.7% on Thursday . The company traded as low as $61.75 and last traded at $60.62. Approximately 8,610 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 229,025 shares. The stock had previously closed at $64.26.

Key CorVel News

Here are the key news stories impacting CorVel this week:

• Positive Sentiment: CorVel reported fiscal 2026 revenue of $959 million, up 7% year over year, while EPS rose 17% to $2.14, showing continued top-line growth and improving profitability. CorVel Announces Revenues and Earnings
• Positive Sentiment: Q4 revenue increased to $248.6 million and EPS climbed 20% to $0.61, supported by stronger gross profit and margin expansion. CorVel Announces Revenues and Earnings
• Positive Sentiment: Management highlighted strong demand for CERIS, its healthcare payment accuracy platform, plus continued investment in AI, automation, and connectivity, which may support future growth and revenue visibility. CorVel Earnings Call Highlights CERIS-Driven Growth
• Neutral Sentiment: CorVel ended the quarter with $233 million in cash and no borrowings, and it repurchased $20.1 million of stock, underscoring a strong balance sheet and shareholder returns. CorVel Announces Revenues and Earnings
• Negative Sentiment: Recent insider-trading data shows only sales and no purchases over the past six months, which can sometimes weigh on sentiment.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, April 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

CorVel Stock Down 3.6%

The company has a market capitalization of $3.17 billion, a PE ratio of 30.35 and a beta of 0.98. The business’s 50 day simple moving average is $55.50 and its 200 day simple moving average is $61.82.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, May 19th. The business services provider reported $0.61 EPS for the quarter. CorVel had a net margin of 11.23% and a return on equity of 30.15%. The company had revenue of $248.55 million during the quarter.

Insider Buying and Selling

In other CorVel news, insider Maxim Shishin sold 2,400 shares of the company’s stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $54.00, for a total transaction of $129,600.00. Following the completion of the sale, the insider directly owned 7,050 shares of the company’s stock, valued at approximately $380,700. This represents a 25.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 44.56% of the company’s stock.

Institutional Trading of CorVel

A number of hedge funds have recently bought and sold shares of CRVL. Federated Hermes Inc. lifted its position in shares of CorVel by 147.4% in the third quarter. Federated Hermes Inc. now owns 381 shares of the business services provider’s stock worth $29,000 after purchasing an additional 227 shares in the last quarter. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of CorVel in the third quarter worth approximately $31,000. Los Angeles Capital Management LLC purchased a new stake in shares of CorVel in the fourth quarter worth approximately $33,000. Eagle Bay Advisors LLC purchased a new stake in shares of CorVel in the fourth quarter worth approximately $37,000. Finally, Hantz Financial Services Inc. lifted its position in shares of CorVel by 61.3% in the third quarter. Hantz Financial Services Inc. now owns 500 shares of the business services provider’s stock worth $39,000 after purchasing an additional 190 shares in the last quarter. 51.36% of the stock is owned by hedge funds and other institutional investors.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).